<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03673189</url>
  </required_header>
  <id_info>
    <org_study_id>35RC17_8836</org_study_id>
    <nct_id>NCT03673189</nct_id>
  </id_info>
  <brief_title>Sensors for HEalth Recording and Physical Activity Monitoring</brief_title>
  <acronym>SHERPAM</acronym>
  <official_title>Sensors for HEalth Recording and Physical Activity Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LTSI-INSERM U1099</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CIC-IT 14-14</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SHERPAM project is part of a scientific and technological context which aim is to record,&#xD;
      transmit, analyse the physiological parameters of a patient, as well as to record the&#xD;
      feedback to the patient and health professional to suggest the best individualised attitude.&#xD;
      The questions of SHERPAM are generic. However, two specific applications will be addressed,&#xD;
      in which the partners have already acquired some expertise: the recognition and&#xD;
      quantification of physical activity with energy expenditure estimation, and the assessment of&#xD;
      walking ability in patients with obliterative vascular disease in the lower limbs. Another&#xD;
      application concerns the monitoring of the practice of physical activity and some biological&#xD;
      signs in subjects with cardiovascular risk and in cardiac patients (arrhythmogenic diseases).&#xD;
      Despite various clinical contexts and health goals, a common approach will be developed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the SHERPAM Device (DS) by the continuous acquisition and transmission of data&#xD;
      (accelerations, rotations, alterations in thoracic volume, heart rate, electrocardiogram) in&#xD;
      a real life physical activity practice (subjects in their living environment and during their&#xD;
      usual physical practices) using the DS's real-time communication tools, automatic data&#xD;
      processing, and the DS's ability to produce information.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 28, 2018</start_date>
  <completion_date type="Actual">September 12, 2019</completion_date>
  <primary_completion_date type="Actual">September 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, monocentric, with healthy volunteers and patients</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>asses the continuous acquisition of data by sensors</measure>
    <time_frame>every day (during 3 weeks)</time_frame>
    <description>transmission and reception of physiological parameters of a patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Test acceptability of SHERPAM Device</measure>
    <time_frame>after 7 days of use</time_frame>
    <description>questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Test acceptability of Sherpam Device</measure>
    <time_frame>after 21 days of use</time_frame>
    <description>questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Test usability of Sherpam Device</measure>
    <time_frame>after 7 days of use</time_frame>
    <description>questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Test usability of Sherpam Device</measure>
    <time_frame>after 21 days of use</time_frame>
    <description>questionnary</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Physical Activity</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sensors assigned for 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with arythmic disease or peripheral vascular disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sensors assigned for 3 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sensors</intervention_name>
    <description>Acquisition and transmission of exploitable recordings in the public targeted by the DS, that is to say which allow to draw clinical information in relation to the objectives of the DS (detection of the cardiac rhythm): data without artefact (saturation), in a good signal to noise ratio.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with arythmic disease or peripheral vascular disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers Healthy active subjects aged 50 or over (ie without diagnosed&#xD;
             disease, without chronic treatment) and recruited in the sports associations of Ille&#xD;
             et Vilaine (cycle tourism clubs).&#xD;
&#xD;
               -  having benefited from an oral or written prescription of physical activity&#xD;
                  carried out by a health professional and applying this prescription daily in&#xD;
                  autonomy or in a sports club.&#xD;
&#xD;
        Common to all subjects&#xD;
&#xD;
          -  physically active (adherent to a club or sports association or practicing&#xD;
             independently according to the recommendations of their physician);&#xD;
&#xD;
          -  practicing at least once a week;&#xD;
&#xD;
          -  residence located less than 100 km return from Rennes University Hospital&#xD;
&#xD;
          -  affiliate or beneficiary of a social protection scheme;&#xD;
&#xD;
          -  having given his written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Common to all subjects&#xD;
&#xD;
          -  wearing a pacemaker or implanted cardiac defibrillator (precaution because using&#xD;
             telemetry);&#xD;
&#xD;
          -  participation in another research protocol;&#xD;
&#xD;
          -  persons aver 18 yrs-old subject to legal protection (legal safeguards, guardianship,&#xD;
             tutorship), persons deprived of their liberty;&#xD;
&#xD;
          -  pregnant or nursing woman.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carre François, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unité de Biologie et médecine du Sport</name>
      <address>
        <city>Rennes</city>
        <state>Bretagne</state>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2018</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sensors</keyword>
  <keyword>Health Recording</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

